company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:17:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3050987.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:17:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3050987.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:17:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,995961.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:17:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,995961.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:17:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2055026.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:17:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1121957.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:17:48+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,241278.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:17:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2242788.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:17:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3606023.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:17:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1550997.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:17:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1550997.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:17:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1550997.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:17:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1552254.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:17:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1552254.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:17:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,77600000.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:17:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:17:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,77600000.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:17:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:17:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,82912179.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:17:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:16:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3122060.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:16:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3122060.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:16:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1079514.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:16:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1079514.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:16:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2042546.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:16:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1170041.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:16:12+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,204750.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:16:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2332712.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:16:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3707503.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:16:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1664957.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:16:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1664957.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:16:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1664957.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:16:12+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,33557.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:16:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1631400.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:16:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1631400.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:16:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,81600000.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:16:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:16:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,81600000.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:16:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:16:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,83615043.0
Antares Pharma Inc,ATRS,,0001016169,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 17:16:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3569547.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3569547.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1452841.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1452841.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2116706.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1490106.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,288794.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1749336.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3528236.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1411530.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1411530.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,30897.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1380633.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1380633.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1380633.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69000000.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,69000000.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,85719683.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 16:33:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 16:38:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3542873.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 16:38:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3542873.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 16:38:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1393289.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 16:38:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1393289.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 16:38:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2149584.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 16:38:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1276575.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 16:38:00+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,523073.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 16:38:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1946331.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 16:38:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3745979.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 16:38:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1596395.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 16:38:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1596395.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 16:38:00+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,42298.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 16:38:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1554097.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 16:38:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1554097.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 16:38:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1554097.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 16:38:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,77700000.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 16:38:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 16:38:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,77700000.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 16:38:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 16:38:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,95157098.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 16:38:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:52:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3919037.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:52:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3919037.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:52:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1807050.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:52:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1807050.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:52:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2111987.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:52:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1559018.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:52:06+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,390260.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:52:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1429210.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:52:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3378488.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:52:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1266501.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:52:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1266501.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:52:06+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-32758.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:52:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1299259.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:52:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1299259.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:52:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1299259.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:52:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,129900000.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:52:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:52:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,129900000.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:52:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:52:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103311772.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:52:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5427035.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5427035.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2144012.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2144012.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3283023.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3073063.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,-1202127.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1574448.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3445384.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-162361.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,55592.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6725.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,48867.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-113494.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-40437.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-153931.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-153931.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-153931.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,87800000.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,87800000.0
Antares Pharma Inc,ATRS,,0001016169,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,96994779.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6864542.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6864542.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1990831.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1990831.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4873711.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1657541.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,103292.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3209937.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4970770.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-97059.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,22665.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,22665.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-74394.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-74394.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-74394.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-74394.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,103658571.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,103658571.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103658571.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 16:31:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:39:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4523942.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:39:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4523942.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:39:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2531111.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:39:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2531111.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:39:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1992831.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:39:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1881056.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:39:23+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,187594.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:39:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2714718.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:39:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4783368.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:39:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2790537.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:39:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2790537.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:39:23+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-16535.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:39:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2807072.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:39:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2807072.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:39:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2807072.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:39:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,93600000.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:39:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:39:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,93600000.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:39:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:39:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,104551742.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:39:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:19:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5685917.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:19:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5685917.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:19:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3296489.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:19:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3296489.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:19:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2389428.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:19:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1551147.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:19:30+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,237067.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:19:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4120428.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:19:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5908642.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:19:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3519214.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:19:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3519214.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:19:30+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-15025.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:19:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3534239.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:19:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3534239.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:19:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3534239.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:19:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,117800000.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:19:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:19:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,117800000.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:19:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:19:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,108961792.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:19:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5501177.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5501177.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1702041.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1702041.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3799136.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4495309.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,-527953.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4876469.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8843825.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5044689.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,63195.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-61811.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1384.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5043305.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,31560.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5011745.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5011745.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5011745.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114300000.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114300000.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,110185077.0
Antares Pharma Inc,ATRS,,0001016169,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4528222.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4528222.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2027143.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2027143.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2501079.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1950430.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,881253.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3072685.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5904368.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3403289.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3403289.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-5159.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3408448.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3408448.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3408448.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113600000.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,113600000.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,126106713.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q1,2013-01-01,2013-03-31,2014-05-09 17:01:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:02:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5837544.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:02:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5837544.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:02:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3480682.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:02:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3480682.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:02:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2356862.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:02:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1933768.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:02:25+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1158236.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:02:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4395528.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:02:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7487532.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:02:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5130670.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:02:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5130670.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:02:25+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,27414.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:02:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5103256.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:02:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5103256.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:02:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5103256.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:02:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,127600000.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:02:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:02:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,127600000.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:02:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:02:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,126462677.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:02:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:33:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5507824.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:33:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5507824.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:33:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3004602.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:33:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3004602.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:33:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2503222.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:33:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1978144.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:33:18+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,2576247.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:33:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4318011.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:33:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8872402.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:33:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6369180.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:33:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6369180.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:33:18+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,9223.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:33:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6359957.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:33:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6359957.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:33:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6359957.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:33:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,127200000.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:33:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:33:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,127200000.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:33:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:33:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,127162064.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:33:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4744910.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4744910.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,684803.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,684803.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4060107.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11145874.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,-4615736.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3477147.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10007285.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5947178.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,111577.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-68036.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,43541.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5903637.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-300000.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-31478.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5635115.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5635115.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5635115.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,128200000.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,128200000.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,126897247.0
Antares Pharma Inc,ATRS,,0001016169,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5202195.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5202195.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1176745.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1176745.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4025450.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8300168.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4533626.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12833794.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8808344.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8808344.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,13739.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8794605.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8794605.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8794605.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,125600000.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,125600000.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,129656257.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 17:01:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6326785.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6326785.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2130080.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2130080.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4196705.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9344910.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3942948.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13287858.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9091153.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9091153.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:51+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-6572.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9097725.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9097725.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9097725.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,130000000.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,130000000.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,130051896.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:03:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:03:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6570581.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:03:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6570581.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:03:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2507366.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:03:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2507366.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:03:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4063215.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:03:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6810089.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:03:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4426730.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:03:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11236819.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:03:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7173604.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:03:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7173604.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:03:26+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-12837.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:03:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7186441.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:03:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7186441.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:03:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7186441.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:03:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,143700000.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:03:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:03:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,143700000.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:03:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:03:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,130771380.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 17:03:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8402104.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8402104.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5422504.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5422504.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2979600.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7285082.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5734712.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13019794.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10040194.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,76661.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-90081.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13420.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10053614.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,25000.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,5670.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10072944.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10072944.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10072944.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,130200000.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,130200000.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,130549701.0
Antares Pharma Inc,ATRS,,0001016169,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8348037.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8348037.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3674729.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3674729.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4673308.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7037290.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4377981.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11415271.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6741963.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6741963.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-45711.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6787674.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6787674.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6787674.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,135800000.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,135800000.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,131744741.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:55:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:00:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14420391.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:00:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14420391.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:00:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4708094.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:00:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4708094.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:00:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9712297.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:00:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6605030.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:00:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4568732.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:00:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11173762.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:00:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1461465.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:00:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1461465.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:00:02+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-45181.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:00:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1506646.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:00:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1506646.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:00:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1506646.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:00:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,150700000.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:00:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:00:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,150700000.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:00:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:00:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,144650269.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 15:00:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11085752.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11085752.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5099763.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5099763.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5985989.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6611169.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5142387.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11753556.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5767567.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5767567.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:11+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,29526.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5738041.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5738041.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5738041.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,143500000.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,143500000.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,154808641.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11803820.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11803820.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5975414.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5975414.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5828406.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6677511.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5641900.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12319411.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6491005.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-22000.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22000.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6513005.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,175000.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,61366.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6626639.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6626639.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6626639.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,147600000.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,147600000.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,146594079.0
Antares Pharma Inc,ATRS,,0001016169,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12318772.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12318772.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6775741.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6775741.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5543031.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7603178.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5648029.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13251207.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7708176.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7708176.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,52066.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7656110.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7656110.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7656110.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,153100000.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,153100000.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,154858079.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:42:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12228390.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12228390.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7318098.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7318098.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4910292.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7014520.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3948020.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10962540.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6052248.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6052248.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:45+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-9215.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6061463.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6061463.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6061463.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,151500000.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,151500000.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,154936096.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:28:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:52:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13478763.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:52:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13478763.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:52:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8033721.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:52:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8033721.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:52:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5445042.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:52:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5622937.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:52:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5958550.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:52:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11581487.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:52:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6136445.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:52:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6136445.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:52:52+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,15462.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:52:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6120983.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:52:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6120983.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:52:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6120983.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:52:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,153000000.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:52:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:52:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,153000000.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:52:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:52:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,155060811.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:52:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14196075.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14196075.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6689440.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6689440.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7506635.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7689365.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4037401.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11726766.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4220131.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-122000.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-122000.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4342131.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,100000.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-58313.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4500444.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4500444.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4500444.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,152100000.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,152100000.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,154992000.0
Antares Pharma Inc,ATRS,,0001016169,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12007000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12007000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6219000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6219000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5788000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7467000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3087000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10554000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4766000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4766000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,30000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4736000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4736000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4736000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,157900000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,157900000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,155215000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:01:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:30:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13416000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:30:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13416000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:30:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5617000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:30:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5617000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:30:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7799000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:30:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7360000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:30:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3159000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:30:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10519000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:30:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2720000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:30:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,168000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:30:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-168000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:30:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2888000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:30:16+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,48000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:30:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2840000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:30:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2840000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:30:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2840000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:30:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,142000000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:30:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:30:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,142000000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:30:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:30:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,155926000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:30:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:42:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15052000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:42:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15052000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:42:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8523000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:42:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8523000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:42:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6529000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:42:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8186000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:42:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3289000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:42:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11475000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:42:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4946000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:42:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,626000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:42:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-626000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:42:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5572000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:42:49+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,119000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:42:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5453000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:42:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5453000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:42:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5453000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:42:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,181800000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:42:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:42:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,181800000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:42:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:42:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,156401000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:42:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,79726000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,79726000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34573000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34573000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,45153000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8633000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2319000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,38220000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-860000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48312000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3159000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,629000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,271000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-358000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3517000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-197000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3714000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3714000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3714000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,152200000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,152200000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,156054000.0
Antares Pharma Inc,ATRS,,0001016169,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12703000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12703000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7186000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7186000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5517000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8236000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2900000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11136000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5619000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,631000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-631000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6250000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,57000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6193000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6193000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6193000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,154800000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,154800000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,156724000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q1,2018-01-01,2018-03-31,2019-05-02 16:28:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:01:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14162000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:01:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14162000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:01:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6960000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:01:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6960000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:01:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7202000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:01:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7883000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:01:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3230000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:01:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11113000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:01:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3911000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:01:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,654000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:01:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-654000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:01:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4565000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:01:33+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,45000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:01:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4520000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:01:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4520000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:01:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4520000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:01:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,150700000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:01:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:01:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,150700000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:01:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:01:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,157024000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 16:01:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:14:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17868000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:14:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17868000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:14:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7289000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:14:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7289000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:14:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10579000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:14:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8747000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:14:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3191000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:14:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11938000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:14:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1359000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:14:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,674000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:14:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-674000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:14:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2033000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:14:57+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,97000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:14:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1936000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:14:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1936000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:14:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1936000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:14:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,157471000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:14:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:14:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,157471000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:14:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:14:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,193600000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 16:14:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,89128000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,89128000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,40695000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,40695000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,48433000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11896000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3007000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,39242000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-12500000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41645000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6788000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,716000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,261000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-455000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6333000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-199000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6134000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6134000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6134000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,162900000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,162900000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,157407000.0
Antares Pharma Inc,ATRS,,0001016169,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23286000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23286000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10946000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10946000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12340000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14935000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2387000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17322000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4982000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,661000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,104000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-557000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5539000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5539000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5539000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5539000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,184600000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,184600000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,160446000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 16:43:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:01:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28433000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:01:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28433000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:01:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,12441000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:01:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,12441000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:01:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15992000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:01:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15087000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:01:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2494000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:01:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17581000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:01:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1589000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:01:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,712000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:01:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-712000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:01:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2301000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:01:33+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,75000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:01:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2226000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:01:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2226000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:01:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2226000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:01:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,222600000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:01:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:01:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,222600000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:01:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:01:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,162734000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 16:01:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:14:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,34306000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:14:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,34306000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:14:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13062000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:14:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13062000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:14:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21244000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:14:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16385000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:14:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2863000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:14:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19248000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:14:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1996000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:14:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1097000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:14:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1097000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:14:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,899000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:14:57+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,144000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:14:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1043000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:14:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1043000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:14:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1043000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:14:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,163119000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:14:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.01
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:14:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,168503000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:14:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.01
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:14:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,104300000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 16:14:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.01
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,37839000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,37839000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,14026000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,14026000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23813000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15366000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2880000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18246000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5567000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1079000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,426000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-653000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4914000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-219000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4695000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4695000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4695000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,202700000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,202700000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,162574000.0
Antares Pharma Inc,ATRS,,0001016169,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
